Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_assertion description "[After 24weeks of treatment, percentages of IFN?-induced pSTAT1+ and IL-10-induced pSTAT3+ monocytes in RA patients increased, reaching levels comparable to HDs. pSTAT1+ and pSTAT3+ cells correlated inversely with RA disease activity index and levels of pSTAT+ cells at baseline were higher in patients with good EULAR response to tocilizumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_assertion evidence source_evidence_literature NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_assertion SIO_000772 25847223 NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_assertion wasDerivedFrom befree-2016 NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_assertion wasGeneratedBy ECO_0000203 NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.
- befree-2016 importedOn "2016-02-19" NP1276219.RA0QEFPvy_LrXxgjUPaxF9klAz31Usq-0B-agxiLUn8NA130_provenance.